ARMISTICE CAPITAL, LLC - Q3 2019 holdings

$1.51 Billion is the total value of ARMISTICE CAPITAL, LLC's 66 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 86.9% .

 Value Shares↓ Weighting
SPY SellSPDR S&P 500 ETF TRput$237,416,000
-40.0%
8,000
-99.4%
15.74%
-36.9%
IWM NewISHARES TRput$90,804,0006,000
+100.0%
6.02%
CERC BuyCERECOR INC$68,048,000
-32.1%
20,683,233
+12.2%
4.51%
-28.7%
CELG BuyCELGENE CORP$50,842,000
+37.5%
512,000
+28.0%
3.37%
+44.6%
EPC NewEDGEWELL PERS CARE COcall$48,735,00015,000
+100.0%
3.23%
VNDA BuyVANDA PHARMACEUTICALS INC$47,117,000
+5.9%
3,548,000
+12.3%
3.12%
+11.3%
AMAG BuyAMAG PHARMACEUTICALS INC$46,893,000
+23.5%
4,060,000
+6.8%
3.11%
+29.9%
KHC NewKRAFT HEINZ CO$41,903,0001,500,000
+100.0%
2.78%
REGN BuyREGENERON PHARMACEUTICALS$41,055,000
+5.8%
148,000
+19.4%
2.72%
+11.2%
HAIN SellHAIN CELESTIAL GROUP INCcall$36,508,000
-16.6%
17,000
-99.2%
2.42%
-12.4%
WBT SellWELBILT INC$35,271,000
-3.6%
2,092,000
-4.6%
2.34%
+1.3%
ENR SellENERGIZER HLDGS INC NEW$34,864,000
-33.1%
800,000
-40.7%
2.31%
-29.6%
ENTA BuyENANTA PHARMACEUTICALS INC$34,846,000
+8.7%
580,000
+52.6%
2.31%
+14.3%
BIIB BuyBIOGEN INC$34,457,000
+426.2%
148,000
+428.6%
2.28%
+453.0%
INCY BuyINCYTE CORP$31,770,000
+64.0%
428,000
+87.7%
2.11%
+72.5%
ORLY NewO REILLY AUTOMOTIVE INC NEW$26,899,00067,500
+100.0%
1.78%
FL BuyFOOT LOCKER INC$26,543,000
+322.1%
615,000
+310.0%
1.76%
+344.2%
DPLO BuyDIPLOMAT PHARMACY INC$26,460,000
+35.8%
5,400,000
+68.8%
1.75%
+42.7%
LULU BuyLULULEMON ATHLETICA INC$25,992,000
+167.1%
135,000
+150.0%
1.72%
+181.1%
TGT BuyTARGET CORP$25,658,000
+218.5%
240,000
+158.1%
1.70%
+234.6%
VFC NewV F CORP$25,362,000285,000
+100.0%
1.68%
CMG NewCHIPOTLE MEXICAN GRILL INC$25,214,00030,000
+100.0%
1.67%
ASMB BuyASSEMBLY BIOSCIENCES INC$24,260,000
-10.1%
2,468,000
+23.4%
1.61%
-5.5%
ONCE BuySPARK THERAPEUTICS INC$24,245,000
+248.2%
250,000
+267.6%
1.61%
+266.1%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$24,114,000
+244.2%
578,000
+261.2%
1.60%
+261.5%
RL NewRALPH LAUREN CORPcl a$22,149,000232,000
+100.0%
1.47%
DBX BuyDROPBOX INCcl a$20,170,000
-15.2%
1,000,000
+5.3%
1.34%
-10.9%
WEN NewWENDYS CO$19,980,0001,000,000
+100.0%
1.32%
UNH NewUNITEDHEALTH GROUP INC$19,124,00088,000
+100.0%
1.27%
FTDR SellFRONTDOOR INC$19,039,000
-12.6%
392,000
-21.6%
1.26%
-8.1%
VYGR BuyVOYAGER THERAPEUTICS INC$18,862,000
-26.0%
1,096,000
+17.1%
1.25%
-22.2%
ATRS SellANTARES PHARMA INC$18,812,000
-4.7%
5,624,000
-6.3%
1.25%
+0.2%
UTHR SellUNITED THERAPEUTICS CORP DEL$18,343,000
-27.5%
230,000
-29.0%
1.22%
-23.7%
BOLD NewAUDENTES THERAPEUTICS INC$17,865,000636,000
+100.0%
1.18%
WING NewWINGSTOP INC$12,917,000148,000
+100.0%
0.86%
QSR SellRESTAURANT BRANDS INTL INC$12,805,000
+0.6%
180,000
-1.6%
0.85%
+5.9%
LOW SellLOWES COS INC$12,755,000
-63.1%
116,000
-66.2%
0.84%
-61.3%
ULTA NewULTA BEAUTY INC$11,655,00046,500
+100.0%
0.77%
MRK NewMERCK & CO INC$11,448,000136,000
+100.0%
0.76%
CRSP NewCRISPR THERAPEUTICS AGnamen akt$10,821,000264,000
+100.0%
0.72%
TSCO NewTRACTOR SUPPLY CO$9,768,000108,000
+100.0%
0.65%
MNKKQ SellMALLINCKRODT PUB LTD COcall$9,640,000
-70.8%
40,000
-98.9%
0.64%
-69.3%
MDGL SellMADRIGAL PHARMACEUTICALS INC$9,312,000
-78.2%
108,000
-73.5%
0.62%
-77.1%
VXRT NewVAXART INC$8,616,00024,000,000
+100.0%
0.57%
EYEG NewEYEGATE PHARMACEUTICALS INC$8,438,0001,792,500
+100.0%
0.56%
TWNK NewHOSTESS BRANDS INCcl a$8,111,000580,000
+100.0%
0.54%
LB NewL BRANDS INC$8,032,000410,000
+100.0%
0.53%
CLVS SellCLOVIS ONCOLOGY INCcall$7,860,000
-76.1%
20,000
-99.1%
0.52%
-74.9%
PRTK SellPARATEK PHARMACEUTICALS INC$6,791,000
-31.3%
1,572,000
-36.6%
0.45%
-27.8%
AYTU BuyAYTU BIOSCIENCE INC$6,195,000
+63.9%
5,120,064
+156.0%
0.41%
+72.7%
AVYA NewAVAYA HLDGS CORP$5,320,000520,000
+100.0%
0.35%
AMZN SellAMAZON COM INC$5,208,000
-31.2%
3,000
-25.0%
0.34%
-27.8%
VRTX NewVERTEX PHARMACEUTICALS INC$5,083,00030,000
+100.0%
0.34%
URBN NewURBAN OUTFITTERS INC$4,775,000170,000
+100.0%
0.32%
PTCT NewPTC THERAPEUTICS INC$4,600,000136,000
+100.0%
0.30%
ALIM BuyALIMERA SCIENCES INC$3,362,000
-35.3%
5,936,000
+1.7%
0.22%
-31.8%
ADMS SellADAMAS PHARMACEUTICALS INC$2,742,000
-83.6%
536,000
-80.1%
0.18%
-82.7%
CPST NewCAPSTONE TURBINE CORP$2,670,000835,000
+100.0%
0.18%
CTXR NewCITIUS PHARMACEUTICALS INC$2,468,0002,197,385
+100.0%
0.16%
SPHS NewSOPHIRIS BIO INC$2,207,0001,793,666
+100.0%
0.15%
VLRXQ  VALERITAS HLDGS INC$1,516,000
-45.4%
1,060,0000.0%0.10%
-42.9%
DYNT SellDYNATRONICS CORP$1,309,000
+37.8%
536,000
-6.9%
0.09%
+45.0%
BLCM NewBELLICUM PHARMACEUTICALS INC$1,087,0001,034,962
+100.0%
0.07%
MDGS NewMEDIGUS LTDsponsored ads$809,0001,285,715
+100.0%
0.05%
AEZS NewAETERNA ZENTARIS INC$494,000480,000
+100.0%
0.03%
BLPH SellBELLEROPHON THERAPEUTICS INC$427,000
-75.1%
885,000
-69.1%
0.03%
-74.1%
ROX ExitCASTLE BRANDS INC$0-1,000,000
-100.0%
-0.03%
ALRN ExitAILERON THERAPEUTICS INC$0-1,200,000
-100.0%
-0.05%
MDGSW ExitMEDIGUS LTD*w exp 07/23/202$0-1,285,715
-100.0%
-0.10%
PLAY ExitDAVE & BUSTERS ENTMT INC$0-50,000
-100.0%
-0.13%
BIG ExitBIG LOTS INC$0-75,000
-100.0%
-0.14%
ZFGN ExitZAFGEN INC$0-2,178,000
-100.0%
-0.16%
TPR ExitTAPESTRY INC$0-100,000
-100.0%
-0.20%
EYEG ExitEYEGATE PHARMACEUTICALS INC$0-17,812,500
-100.0%
-0.27%
SBBP ExitSTRONGBRIDGE BIOPHARMA PLC$0-1,580,000
-100.0%
-0.31%
SPOT ExitSPOTIFY TECHNOLOGY S A$0-48,000
-100.0%
-0.44%
SKX ExitSKECHERS U S A INCcl a$0-252,000
-100.0%
-0.50%
GOOS ExitCANADA GOOSE HOLDINGS INC$0-218,000
-100.0%
-0.53%
KMX ExitCARMAX INC$0-110,000
-100.0%
-0.60%
JACK ExitJACK IN THE BOX INC$0-150,000
-100.0%
-0.77%
CLLS ExitCELLECTIS S Asponsored ads$0-800,000
-100.0%
-0.79%
BLUE ExitBLUEBIRD BIO INC$0-100,000
-100.0%
-0.80%
PLNT ExitPLANET FITNESS INCcl a$0-264,000
-100.0%
-1.21%
CPRX ExitCATALYST PHARMACEUTICALS INC$0-5,000,000
-100.0%
-1.21%
FIVE ExitFIVE BELOW INC$0-213,000
-100.0%
-1.61%
SJM ExitSMUCKER J M CO$0-224,000
-100.0%
-1.63%
RH ExitRH$0-224,000
-100.0%
-1.63%
BURL ExitBURLINGTON STORES INC$0-224,000
-100.0%
-2.40%
EPC ExitEDGEWELL PERS CARE CO$0-1,540,000
-100.0%
-2.62%
DFRG ExitDEL FRISCOS RESTAURANT GROUP$0-6,125,000
-100.0%
-3.07%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1508862000.0 != 1508861000.0)

Export ARMISTICE CAPITAL, LLC's holdings